NCT06538038 2026-03-16
Prospective Non-Interventional Study Comparing Osimertinib +/- Chemotherapy for EGFR-Mutated NSCLC Patients
PrECOG, LLC.
Recruiting
PrECOG, LLC.
Fundación GECP
CHA University
City of Hope Medical Center
Peking University Cancer Hospital & Institute
Second Affiliated Hospital, School of Medicine, Zhejiang University
Sun Yat-sen University
Swami Rama Himalayan University